Publication Name	World Journal of Gastroenterology
Manuscript ID	7841
Country	China

Received	2013-12-02 19:30
Peer-Review Started	2013-12-04 15:01
To Make the First Decision	2013-12-16 17:38
Return for Revision	2013-12-18 16:53
Revised	2014-01-29 07:45
Second Decision	2014-03-05 14:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-03-05 14:46
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-12 10:55
Typeset the Manuscript	2014-03-12 13:00
Publish the Manuscript Online	2014-03-27 12:04

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Autobiography
Article Title	Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Wei Deng, Qi-Wei Wang, Xiao-Tian Zhang, Ming Lu, Jie Li, Yan Li, Ji-Fang Gong, Jun Zhou, Zhi-Hao Lu and Lin Shen
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China 81172110 National High-tech R&D Program of China 2006AA 02A 402-B02 National High-tech R&D Program of China 2012AA 02A 504 Beijing Municipal Science and Technology Commission Program “Exploring the utilization of molecular markers in the individual treatment of gastric cancer based on the clinical research cohort”
Corresponding Author	Xiao-Tian Zhang, Professor, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Haidian District, Beijing 100142, China. zhangxtxx@gmail.com
Key Words	Adjuvant chemotherapy; Gastric cancer; Lymphadenectomy; Fluoropyrimidine; Platinum
Core Tip	Although the ACTS GC and CLASSIC trials demonstrated that postoperative chemotherapy improved overall survival after standard D2 gastrectomy, severe challenges in adjuvant settings remain unsettled, such as low D2 resection rates in some regions. Our retrospective study is complementary to large-scale phase Ⅲ prospective trials, and demonstrated the efficacy and safety of postoperative platinum/fluoropyrimidines in stage Ⅱ/Ⅲ gastric cancer patients accordingto the updated 7th edition staging system after curative gastrectomy with standard or limited lymphadenectomy.
Publish Date	2014-03-27 12:04
Citation	Deng W, Wang QW, Zhang XT, Lu M, Li J, Li Y, Gong JF, Zhou J, Lu ZH, Shen L. Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer. World J Gastroenterol 2014; 20(12): 3356-3363
URL	http://www.wjgnet.com/1007-9327/full/v20/i12/3356.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i12.3356

Full Article (PDF)	WJG-20-3356.pdf
Full Article (Word)	WJG-20-3356.doc
Manuscript File	7841-Review.docx
Answering Reviewers	7841-Answering reviewers.pdf
Copyright License Agreement	7841-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	7841-Language certificate.pdf
Peer-review Report	7841-Peer reviewer(s).pdf
Scientific Editor Work List	7841-Scientific editor work list.doc